Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.
) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day up 0.8%. By the end of trading, Johnson & Johnson fell $0.88 (-1.0%) to $87.53 on light volume. Throughout the day, 6,696,342 shares of Johnson & Johnson exchanged hands as compared to its average daily volume of 9,840,000 shares. The stock ranged in price between $87.39-$88.48 after having opened the day at $88.36 as compared to the previous trading day's close of $88.41. Other companies within the Health Care sector that declined today were:
), down 40.6%,
), down 13.5%,
), down 9.1% and
), down 9.1%.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Johnson & Johnson has a market cap of $248.7 billion and is part of the drugs industry. Shares are up 26.1% year to date as of the close of trading on Friday. Currently there are 10 analysts that rate Johnson & Johnson a buy, no analysts rate it a sell, and 9 rate it a hold.
TheStreet Ratings rates
Johnson & Johnson
. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.
- You can view the full Johnson & Johnson Ratings Report.
On the positive front,
), up 27.1%,
), up 22.4%,
), up 18.8% and
), up 15.2% , were all gainers within the health care sector with
) being today's featured health care sector leader.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider
) while those bearish on the health care sector could consider
- Find other investment ideas from our top rated ETFs lists.